Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients

被引:23
|
作者
Slimani, Afef [1 ]
Jelassi, Awatef [1 ]
Jguirim, Imen [1 ]
Najah, Mohamed [1 ]
Rebhi, Lamia [2 ]
Omezzine, Asma [2 ]
Maatouk, Faouzi [3 ]
Ben Hamda, Khaldoun [3 ]
Kacem, Maha [4 ]
Rabes, Jean-Pierre [5 ]
Abifadel, Marianne [6 ]
Boileau, Catherine [5 ,7 ]
Rouis, Mustapha [8 ]
Slimane, Mohamed Naceur [1 ]
Varret, Mathilde [7 ]
机构
[1] Fac Med, Unit Res Genet & Biol Factors Atherosclerosis, Monastir 5000, Tunisia
[2] Sahloul Univ Hosp, Dept Biochem, URMSP 28 04, Sousse, Tunisia
[3] Fattouma Bourguiba Hosp, Dept Cardiovasc Dis, Monastir 5000, Tunisia
[4] Farhat Hachad Hosp, Dept Endocrinol, Sousse, Tunisia
[5] Univ Versailles St Quentin En Yvelines, Hop A Pare, AP HP, Versailles, France
[6] Univ St Joseph, Fac Pharm, Beirut, Lebanon
[7] Univ Paris Denis Diderot, CHU Xavier Bichat, INSERM, U698, Paris, France
[8] Univ Paris 06, UMR Physiol & Physiopathol 7079, Paris, France
关键词
Familial hypercholesterolemia; LDLR gene; PCSK9; gene; Phenotypic variability; APOLIPOPROTEIN-E; CHOLESTEROL LEVELS; POLYMORPHISMS; SPECTRUM; VARIANT;
D O I
10.1016/j.atherosclerosis.2012.02.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Autosomal dominant hypercholesterolemia (ADH) is commonly caused by mutations in the low-density lipoprotein (LDL) receptor gene (LDLR), in the apolipoprotein B-100 gene (APOB), or in the proprotein convertase subtilisin kexine 9 gene (PCSK9). ADH subjects carrying a mutation in LDLR present highly variable plasma LDL-cholesterol (LDL-C). This variability might be due to environmental factors or the effect of some modifying genes such as PCSK9 and APOE. Aims: We investigated the molecular basis of thirteen Tunisian ADH families and attempted to determine the impact of PCSK9 and APOE gene variations on LDL-cholesterol levels and on the variable phenotypic expression of the disease. Methods and results: Fifty six subjects were screened for mutations in the LDLR gene through direct sequencing. The causative mutation was found to segregate with the disease in each family and a new frameshift mutation, p.Met767CysfsX21, was identified in one family. The distribution of total-and LDL-cholesterol levels, adjusted for age and gender, among homozygous and heterozygous ADH patients varied widely. Within seven families, nine subjects presented low LDL-cholesterol levels despite carrying a mutation in the LDLR gene. To identify the molecular actors underlying this phenotypic variability, the PCSK9 gene was screened using direct sequencing and/or enzymatic restriction analysis, and the apo E genotypes were determined. A new missense variation (p.Pro174Ser) in the PCSK9 gene was identified and characterized as a new putative loss-of-function mutation. Conclusion: Genetic variations in PCSK9 and APOE genes could explain only part of the variability observed in the phenotypic expression in Tunisian ADH patients carrying mutations in the LDLR gene. Other genetic variants and environmental factors very probably act to fully explain this phenotypic variability. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:158 / 166
页数:9
相关论文
共 50 条
  • [21] ANALYSIS OF THE LDLR, APOB, PCSK9 AND LDLRAP1 GENES VARIABILITY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN WEST SIBERIA USING TARGETED HIGH THROUGHPUT RESEQUENCING
    Shakhtshneider, E.
    Ivanoshchuk, D.
    Orlov, P.
    Timoshchenko, O.
    Voevoda, M.
    ATHEROSCLEROSIS, 2019, 287 : E285 - E285
  • [22] INSIGHTS INTO THE VIETNAM FAMILIAL HYPERCHOLESTEROLEMIA REGISTRY: CHARACTERIZING MUTATIONS IN LDLR, APOB AND PCSK9 PROTEINS AT A STRUCTURAL AND FUNCTIONAL LEVEL
    Kim, Thanh
    Ngoc Nguyen
    Tung Le
    An Le
    Loi Do
    Huong Truong
    ATHEROSCLEROSIS, 2024, 395
  • [23] PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies
    El Khoury, Petra
    Elbitar, Sandy
    Ghaleb, Youmna
    Abou Khalil, Yara
    Varret, Mathilde
    Boileau, Catherine
    Abifadel, Marianne
    CURRENT ATHEROSCLEROSIS REPORTS, 2017, 19 (12)
  • [24] PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 Therapies
    Petra El Khoury
    Sandy Elbitar
    Youmna Ghaleb
    Yara Abou Khalil
    Mathilde Varret
    Catherine Boileau
    Marianne Abifadel
    Current Atherosclerosis Reports, 2017, 19
  • [25] PCSK9 gene analysis in Portuguese patients with familial hypercholesterolemia
    Alves, A. C.
    Rato, Q.
    Furtado, A.
    Bourbon, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 214 - 215
  • [26] SCREENING OF PCSK9 GENE IN INDIAN FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS
    Reddy, L. L.
    Ponde, C. K.
    Rajani, R. M.
    Pillai, S.
    Dalal, R. J.
    Vanjani, C. V.
    Dalal, J.
    Ashavaid, T. F.
    ATHEROSCLEROSIS, 2019, 287 : E212 - E212
  • [27] PCSK9 inhibition in the management of familial hypercholesterolemia
    Ogura, Masatsune
    JOURNAL OF CARDIOLOGY, 2018, 71 (1-2) : 1 - 7
  • [28] MUTATIONS IN LDLR, APOB, PCSK9 AND APOE GENES CONTRIBUTE TO THE GENETIC SPECTRUM OF FAMILIAL HYPERCHOLESTEROLAEMIA IN THE NORTH OF ENGLAND
    Johnston, L.
    Potter, A.
    Carey, P.
    Luvai, A.
    McKenna, P.
    Weaver, J.
    Pattman, S.
    Kamaruddin, S.
    Arutchevelam, V.
    Anderson, M.
    Burns, M.
    Hopper, N.
    Sutton, R.
    McAnulty, C.
    Curtis, A.
    Neely, R.
    ATHEROSCLEROSIS, 2018, 275 : E79 - E79
  • [29] Patients With LDLR and PCSK9 Gene Variants Experienced Higher Incidence of Cardiovascular Outcomes in Heterozygous Familial Hypercholesterolemia
    Doi, Takahito
    Hori, Mika
    Harada-Shiba, Mariko
    Kataoka, Yu
    Onozuka, Daisuke
    Nishimura, Kunihiro
    Nishikawa, Ryo
    Tsuda, Kosuke
    Ogura, Masatsune
    Son, Cheol
    Miyamoto, Yoshihiro
    Noguchi, Teruo
    Shimokawa, Hiroaki
    Yasuda, Satoshi
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (04): : 1 - 11
  • [30] PCSK9 INHIBITOR UTILIZATION IN FAMILIAL HYPERCHOLESTEROLEMIA
    Jackson, Candace
    Deng, Yihong
    Yao, Xiaoxi
    Van Houten, Holly
    Shah, Nilay
    Kopecky, Stephen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1873 - 1873